Is On Investors’ Radar Today Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

Precedence Research, a leading strategic research firm, presents a comprehensive analysis of the AI-driven bioengineering ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

WUHC ’s annual event is the nation’s largest undergraduate healthcare conference. The day included four panels on topics of ...

ARK Invest sold $39M Coinbase stock and bought $28M Bullish shares. Cathie Wood's ETFs shift crypto exposure as exchange stocks face volatility.

Sometimes, an opportunity to buy something is hiding in plain sight ...

ARK Invest sold $22M in Coinbase shares and added Bullish exposure, signaling a quick strategy shift as crypto stocks rallied ...

Cathie Wood’s ARK Invest continued trimming its exposure to Coinbase on Friday, selling roughly $22 million worth of shares across three exchange-traded ...

The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...

When I first read “The Chronology of Water,” I felt seen. It was a gritty, partially Oregon-based coming of age tale. And not ...

For six months, I immersed myself only in books by authors who died by suicide. What began as a literary curiosity turned into an emotional narrowing that reshaped how reading felt. This reflection ...